G. Ralph Corey

Active 1984–2020

103
Papers
23,508
Citations
90
h-index
103
i10-index

Citations

Citations per year for G. Ralph Corey1984: 1 citations1987: 2 citations1988: 2 citations1989: 2 citations1990: 5 citations1991: 1 citations1992: 1 citations1993: 4 citations1994: 3 citations1995: 4 citations1996: 9 citations1997: 15 citations1998: 22 citations1999: 31 citations2000: 39 citations2001: 49 citations2002: 54 citations2003: 76 citations2004: 92 citations2005: 150 citations2006: 138 citations2007: 219 citations2008: 186 citations2009: 285 citations2010: 222 citations2011: 233 citations2012: 199 citations2013: 210 citations2014: 229 citations2015: 276 citations2016: 155 citations2017: 161 citations2018: 126 citations2019: 519 citations2020: 514 citations2021: 407 citations2022: 313 citations2023: 225 citations2024: 357 citations2025: 130 citations2026: 1 citations1985–1986: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,859 citing papers, 31.2% of this breakdownUnited Kingdom: 387 citing papers, 6.5% of this breakdownFrance: 320 citing papers, 5.4% of this breakdownGermany: 275 citing papers, 4.6% of this breakdownSpain: 270 citing papers, 4.5% of this breakdownItaly: 242 citing papers, 4.1% of this breakdownChina: 230 citing papers, 3.9% of this breakdownCanada: 200 citing papers, 3.4% of this breakdownAustralia: 180 citing papers, 3% of this breakdownSwitzerland: 158 citing papers, 2.6% of this breakdownNetherlands: 157 citing papers, 2.6% of this breakdownBelgium: 99 citing papers, 1.7% of this breakdown
0%31.2%Other 26.5%

Fields

  • Medicine71.6%
  • Biochemistry, Genetics and Molecular Biology11.8%
  • Immunology and Microbiology4.6%
  • Health Professions3.8%
  • Engineering2.1%
  • Agricultural and Biological Sciences1.9%
  • Other4.2%

Topics

  • Antimicrobial Resistance in Staphylococcus13.5%
  • Infective Endocarditis Diagnosis and Management8.8%
  • Bacterial Identification and Susceptibility Testing5.4%
  • Streptococcal Infections and Treatments4%
  • Bacterial biofilms and quorum sensing3.9%
  • Antibiotic Resistance in Bacteria3.2%
  • Other61.2%

Coauthors

All papers

Open in search
  1. An Integrated Clinico-Metabolomic Model Improves Prediction of Death in Sepsis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , G. Ralph Corey, Geoffrey S. Ginsburg, Charles B. Cairns, Ronny Otero, Vance G. Fowler, Emanuel P. Rivers, Christopher W. Woods, Stephen F. Kingsmore - Science Translational Medicine 2013 cited by 511

  2. Daptomycin versus Standard Therapy for Bacteremia and Endocarditis Caused by Staphylococcus aureus

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2006 cited by 1,463

  3. Exebacase for patients with Staphylococcus aureus bloodstream infection and endocarditis

    Authors: , , , , , , , , , , , , , , - Journal of Clinical Investigation 2020 cited by 124

  4. Effect of an Investigational Vaccine for Preventing Staphylococcus aureus Infections After Cardiothoracic Surgery

    Authors: , , , , , , , , , , , , , , , , , - JAMA 2013 cited by 365

  5. Clinical Identifiers of Complicated Staphylococcus aureus Bacteremia

    Authors: , , , , , , , , - Archives of Internal Medicine 2003 cited by 646

  6. In Vitro Activity of Eravacycline against Gram-Negative Bacilli Isolated in Clinical Laboratories Worldwide from 2013 to 2017

    Authors: , , , , , , , - Antimicrobial Agents and Chemotherapy 2019 cited by 97

  7. Epidemiology of Methicillin‐ResistantStaphylococcus aureus

    Authors: , - Clinical Infectious Diseases 2008 cited by 810

  8. Staphylococcus aureus Endocarditis

    Authors: , , , , , , , , , , , , , , , , , , , , , - JAMA 2005 cited by 1,168

  9. Methicillin-Resistant Staphylococcus aureus: An Evolving Pathogen

    Authors: , - Clinical Infectious Diseases 2013 cited by 333

  10. Phase II, Randomized, Double-Blind, Multicenter Study Comparing the Safety and Pharmacokinetics of Tefibazumab to Placebo for Treatment of Staphylococcus aureus Bacteremia

    Authors: , , , , , , , , , , , , , , , , - Antimicrobial Agents and Chemotherapy 2006 cited by 155

  11. Enterococcal endocarditis in the beginning of the 21st century: analysis from the International Collaboration on Endocarditis-Prospective Cohort Study

    Authors: , , , , , , , , , - Clinical Microbiology and Infection 2013 cited by 175

  12. Impact of Cardiac Implantable Electronic Device Infection

    Authors: , , , , , , , , , , , , , , , , - Circulation Arrhythmia and Electrophysiology 2020 cited by 83

  13. Persistent Bacteremia Due to Methicillin‐ResistantStaphylococcus aureusInfection Is Associated withagrDysfunction and Low‐Level In Vitro Resistance to Thrombin‐Induced Platelet Microbicidal Protein

    Authors: , , , , , , , , , , , , , - The Journal of Infectious Diseases 2004 cited by 350

  14. Initial Low‐Dose Gentamicin forStaphylococcus aureusBacteremia and Endocarditis Is Nephrotoxic

    Authors: , , , , , , , , , , - Clinical Infectious Diseases 2009 cited by 306

  15. Tedizolid for 6 days versus linezolid for 10 days for acute bacterial skin and skin-structure infections (ESTABLISH-2): a randomised, double-blind, phase 3, non-inferiority trial

    Authors: , , , , , - The Lancet Infectious Diseases 2014 cited by 304

  16. Single-Dose Oritavancin in the Treatment of Acute Bacterial Skin Infections

    Authors: , , , , , , , , , , , , - New England Journal of Medicine 2014 cited by 302

  17. An integrated transcriptome and expressed variant analysis of sepsis survival and death

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Genome Medicine 2014 cited by 104

  18. Working formulation for the standardization of definitions of infections in patients using ventricular assist devices

    Authors: , , , , , , , , , , , , , , , , , - The Journal of Heart and Lung Transplantation 2011 cited by 370

  19. Inoculum Effect with Cefazolin among Clinical Isolates of Methicillin-Susceptible Staphylococcus aureus : Frequency and Possible Cause of Cefazolin Treatment Failure

    Authors: , , , , , , , - Antimicrobial Agents and Chemotherapy 2009 cited by 148

  20. Single-Dose Oritavancin Versus 7–10 Days of Vancomycin in the Treatment of Gram-Positive Acute Bacterial Skin and Skin Structure Infections: The SOLO II Noninferiority Study

    Authors: , , , , , , , , , , , - Clinical Infectious Diseases 2014 cited by 218

  21. Impact of Early Valve Surgery on Outcome of Staphylococcus aureus Prosthetic Valve Infective Endocarditis: Analysis in the International Collaboration of Endocarditis–Prospective Cohort Study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Silvia Kogan, Denis Spelman, Eugene Athan, Owen Harris, Karina Kennedy, Ren Tan, David Gordon, Lito E. Papanicolas, Damon P. Eisen, Leeanne Grigg, Alan Street, Tony M. Korman, Despina Kotsanas, Robyn Dever, Robyn Dever, Pam Koneçny, Richard Lawrence, David Rees, Suzanne Ryan, Michael P. Feneley, John Harkness, John Harkness, Suzanne Ryan, Suzanne Ryan, Suzanne Ryan, Suzanne Ryan, Jeffrey J. Post, Porl Reinbott, Porl Reinbott, Rainer Gattringer, Franz Wiesbauer, Adriana Ribas Andrade, Ana Cláudia Passos de Brito, Armênio Costa Guimarães, Max Grinberg, Alfredo José Mansur, Rinaldo Focaccia Siciliano, Tânia Mara Varejão Strabelli, Marcelo Luiz Campos Vieira, Regina Aparecida de Medeiros Tranchesi, Marcelo Goulart Paiva, Cláudio Querido Fortes, Auristela de Oliveira Ramos, G. Ferraiuoli, W. Golebiovski, Cristiane da Cruz Lamas, Marisa Santos, Clara Weksler, James A. Karlowsky, Yoav Keynan, Andrew M. Morris, Ethan Rubinstein, Sandra Braun Jones, Patricia García, Mauricio Cereceda, Alberto Fíca, Rodrigo Montagna Mella, Bruno Baršić, Suzana Bukovski, Vladimir Krajinović, Ana Pangerčić, Igor Rudež, Josip Vincelj, Tomáš Freiberger, Jiří Pol, Barbora Žaloudíková, Zainab Ashour, Amani El‐Kholy, Marwa Mishaal, Hussien Rizk and 240 more - Clinical Infectious Diseases 2014 cited by 113

  22. Good Studies Evaluate the Disease While Great Studies Evaluate the Patient: Development and Application of a Desirability of Outcome Ranking Endpoint for Staphylococcus aureus Bloodstream Infection

    Authors: , , , , , , , , , , , , , , - Clinical Infectious Diseases 2018 cited by 77

  23. Role of Echocardiography in Evaluation of Patients With Staphylococcus aureusBacteremia: Experience in 103 Patients

    Authors: , , , , , , , , , , - Journal of the American College of Cardiology 1997 cited by 420

  24. Risk Factors For Hematogenous Complications of Intravascular Catheter-Associated Staphylococcus aureus Bacteremia

    Authors: , , , , , , , , , - Clinical Infectious Diseases 2005 cited by 260